Cinemark Seen Benefiting From Stronger Film Slate, Pricing Gains, Wedbush Says

MT Newswires Live
05/04

Cinemark (CNK) is positioned to benefit from a more consistent film release slate over the coming quarters, along with ongoing gains in pricing, premium format adoption and theater investment initiatives, Wedbush Securities said in a Monday note.

The analysts said Cinemark delivered strong Q1 results with revenue, adjusted EBITDA, and earnings per share all exceeding expectations. The performance was driven by robust domestic box office trends, higher attendance and improved ticket pricing.

Wedbush highlighted strong concessions performance, including record domestic food and beverage per-cap spending, supported by pricing actions and operational efficiencies. The note also pointed to steady market share, a strong loyalty program and expanding alternative content offerings.

The company can benefit from investments in premium seating, laser projection and IMAX expansion. It also sees upside from new builds and potential acquisitions. Shareholder returns through dividends and buybacks remain a key part of the story and a stronger film slate should support performance over the rest of the year, according to the note.

Wedbush maintained its outperform rating on the stock with a price target of $37.

Shares of Cinemark were up 1.6% in Monday trading.

Price: 28.07, Change: +0.45, Percent Change: +1.63

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10